These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 337469)

  • 1. [Comparison between the presence of specific circulating immune complexes and the leukocyte migration inhibition test in different clinical forms of hepatitis B].
    Krafft T; Peitrequin R; Frei PC
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1759-61. PubMed ID: 337469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune mechanisms in hepatitis B. New aspects and consequent practices].
    Frei PC
    Schweiz Med Wochenschr; 1977 Apr; 107(15):510-14. PubMed ID: 854720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg].
    Hashimoto Y; Sekiguchi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus infection: detection of circulating HBsAg/IgM antibody immune complexes.
    Surelia P; Boxall EH
    Med Lab Sci; 1990 Jul; 47(3):204-9. PubMed ID: 2402200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific cellular immunity of Australia antigen. Preliminary reports on different forms of b hepatitis].
    Erard PH; Frei PC; Peitrequin R; Hofstetter JR; Magnenat P
    Schweiz Med Wochenschr; 1974 Dec; 104(50):1882-5. PubMed ID: 4445863
    [No Abstract]   [Full Text] [Related]  

  • 6. [Early prognostic significance of hepatitis B surface antigen specific circulating immune complexes in acute type B viral hepatitis].
    Markus R
    Z Gesamte Inn Med; 1990 Oct; 45(20):623-5. PubMed ID: 2099582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of the migration of humanleukocytes by the surface antigen of the hepatitis B virus].
    Houle G; Gladu Y; Marleau D; Richer G
    Union Med Can; 1977 May; 106(5):677-82. PubMed ID: 867607
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of cell-mediated immunity in acute hepatitis B in the leukocyte migration inhibition test].
    Traditi F; Rossi F; Cirelli A
    Boll Soc Ital Biol Sper; 1975 Nov; 51(21):1548-51. PubMed ID: 821498
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of the leukocyte migration inhibition reaction to HBsAg in viral hepatitis B in children].
    Cherednichenko TV; Tamarova LD
    Vopr Okhr Materin Det; 1980 Sep; 25(9):8-12. PubMed ID: 7423898
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cell-mediated immunity to surface and core antigens of the type B hepatitis virus. I. Studies performed in the course of acute and chronic disease].
    Szymańska I
    Med Dosw Mikrobiol; 1977; 29(2):135-46. PubMed ID: 895251
    [No Abstract]   [Full Text] [Related]  

  • 11. [Course control and significance of circulating HBsAg-specific immune complexes in acute viral hepatitis B].
    Markus R; Baumgarten R; Fengler JD; Richter H; Apostoloff E
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(4):229-42. PubMed ID: 3803280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity in response to HBs antigen.
    Szkaradkiewicz A; Kiczka W
    Z Immunitatsforsch Immunobiol; 1978 Sep; 154(5):463-70. PubMed ID: 726550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific immunotherapy proposed for hepatitis B virus infection.
    Vyas GN; Schmid R; Ibrahim AB; Rao KR
    Dev Biol Stand; 1975; 30():350-6. PubMed ID: 1204970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infection due to hepatitis B virus and host immune response].
    Realdi G; Bortolotti F; Alberti A; Fattovich G; Ongaro G
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):323-34. PubMed ID: 1016586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of antigen moiety of HBsAg in the complement fixing immune complexes of hepatitis B virus positive chronic active hepatitis.
    Gupta RC
    Clin Exp Immunol; 1982 Sep; 49(3):543-51. PubMed ID: 7172494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune response and B hepatitis (author's transl)].
    Tittor W; Schwalbach G
    Leber Magen Darm; 1980 Aug; 10(4):179-85. PubMed ID: 7453469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological aspects of hepatitis B virus infection.
    Edgington TS; Chisari FV
    Am J Med Sci; 1975; 270(2):212-27. PubMed ID: 799469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circulating immune complexes in viral hepatitis B and cellular immunity].
    Belozerov ES; Makarova TA
    Klin Med (Mosk); 1983 Feb; 61(2):71-4. PubMed ID: 6601740
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of cellular and humoral immunity during acute and chronic HBSAG+ hepatitis].
    Scalise G; Mura MS
    Recenti Prog Med; 1978 Jul; 65(1):1-28. PubMed ID: 370933
    [No Abstract]   [Full Text] [Related]  

  • 20. [Liver-specific proteins and autoimmunity in inflammatory liver diseases].
    Alberti A; Realdi G; Bortolotti F; Trevisan A; Tremolada F; Rigoli A
    Boll Ist Sieroter Milan; 1976; 55(5):411-25. PubMed ID: 1016592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.